You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Salivary Gland

Showing 1 - 25 of 2,798
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Biomarker Study for Salivary Gland Carcinoma

Not yet recruiting
  • Salivary Gland Tumor
  • Benign Salivary Gland Tumor
  • Sampling
  • Erlangen, Bavaria, Germany
  • +1 more
Sep 21, 2023

GENE EXPRESSION PROFILING IN A VALIDATION COHORT OF LOCALLY

Not yet recruiting
  • Salivary Gland Cancer
  • Observation
  • (no location specified)
Oct 13, 2023

Salivary Gland Tumor, Diagnosis Trial in Thessaloníki (Fine Needle Aspiration, Histologic Examination)

Completed
  • Salivary Gland Tumor
  • Diagnosis
  • Fine Needle Aspiration
  • Histologic Examination
  • Thessaloníki, Greece
    Aristotle University
Sep 11, 2023

Gland, Salivary Gland Cancers Trial in Houston (Sacituzumab Govitecan)

Not yet recruiting
  • Gland
  • Salivary Gland Cancers
  • Sacituzumab Govitecan
  • Houston, Texas
    M D Anderson Cancer Center
May 22, 2023

Advanced Salivary Gland Carcinoma Trial in Shanghai (SHR-A1811, SHR 3680 + leuprolide, SHR-A1921)

Not yet recruiting
  • Advanced Salivary Gland Carcinoma
  • Shanghai, China
    Dongmei Ji
Jun 21, 2023

Recurrent Salivary Gland Infections in Covid-19 Trial in Banha

Active, not recruiting
  • Recurrent Salivary Gland Infections in Covid-19
    • Banhā, Egypt
      Benha university hospitals
    Jun 2, 2023

    Primary Sjögren Syndrome Trial (68Ga-P16-093)

    Not yet recruiting
    • Primary Sjögren Syndrome
    • (no location specified)
    Sep 19, 2023

    PSMA-PET Imaging of Salivary Gland Tumours and Other Rare

    Recruiting
    • Salivary Gland Tumor
    • Rare Malignant Neoplasm
    • 68-Ga PSMA PET scan
    • Singapore, Singapore
      National Cancer Centre Singapore
    Oct 11, 2022

    Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination

    Not yet recruiting
    • Salivary Gland Cancer
    • vedicitumomab (Edisil, RC48）
    • +3 more
    • (no location specified)
    Jun 9, 2023

    Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

    Recruiting
    • Salivary Gland Cancer
    • +2 more
    • Nijmegen, Gelderland, Netherlands
      Radboudumc
    Oct 27, 2022

    Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

    Not yet recruiting
    • Locally Advanced Salivary Gland Carcinoma
    • +3 more
    • Biopsy
    • +3 more
    • (no location specified)
    Jan 10, 2023

    High-grade Salivary Gland Carcinoma Trial in Seoul (nivolumab, docetaxel, cisplatin Group)

    Recruiting
    • High-grade Salivary Gland Carcinoma
    • nivolumab, docetaxel, cisplatin Group
    • Seoul, Korea, Republic of
      Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
    Feb 3, 2023

    Salivary Gland Cancer, HER2 Gene Mutation Trial in Boston (Ado-trastuzumab (T) emtansine (T-DM1), Standard of Care Radiotherapy,

    Recruiting
    • Salivary Gland Cancer
    • HER2 Gene Mutation
    • Ado-trastuzumab (T) emtansine (T-DM1)
    • +2 more
    • Boston, Massachusetts
    • +1 more
    Jan 2, 2023

    Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

    Recruiting
    • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Nov 21, 2023

    Salivary Gland Tumors Trial in Beijing (RC48-ADC)

    Recruiting
    • Salivary Gland Tumors
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Oct 28, 2022

    Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

    Recruiting
    • Metastatic Salivary Gland Carcinoma
    • +4 more
    • New York, New York
      Memorial Sloane Kettering Cancer Center
    Jan 11, 2023

    Salivary Gland Tumor Trial in Philadelphia (MRI)

    Recruiting
    • Salivary Gland Tumor
    • MRI
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Jun 19, 2022

    Salivary Gland Cancer, Salivary Gland Tumors Trial in Novi Sad (Surgical intervention with or without postoperative adjuvant

    Completed
    • Salivary Gland Cancer
    • Salivary Gland Neoplasms
    • Surgical intervention with or without postoperative adjuvant therapy
    • Novi Sad, Serbia
      Clinic for maxillofacial surgery Clinical center of Vojvodina
    May 22, 2022

    Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

    Recruiting
    • Salivary Gland Cancer
    • Nagoya, Aichi, Japan
    • +11 more
    Jan 21, 2023

    Salivary Gland Stone, Salivary Gland Diseases Trial in Alexandria (Minimally invasive techniques)

    Completed
    • Salivary Gland Stone
    • Salivary Gland Diseases
    • Minimally invasive techniques
    • Alexandria, Egypt
      Faculty of Dentistry, Alexandria University
    Apr 20, 2022

    Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)

    Recruiting
    • Salivary Gland Carcinoma
    • Chicago, Illinois
    • +6 more
    Sep 22, 2022

    Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8 Trial in

    Recruiting
    • Metastatic Salivary Gland Carcinoma
    • +5 more
    • Pembrolizumab
    • Pemetrexed Disodium
    • Scottsdale, Arizona
    • +2 more
    Mar 15, 2022

    Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

    Withdrawn
    • Salivary Gland Carcinoma
    • +3 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Feb 5, 2022

    Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in United States (Lenvatinib, Pembrolizumab)

    Recruiting
    • Adenoid Cystic Carcinoma
    • Salivary Gland Cancer
    • Miami, Florida
    • +7 more
    Oct 26, 2022

    Thyroid Cancer, Salivary Gland Cancer Trial in Chicago (Pembrolizumab, Docetaxel)

    Recruiting
    • Thyroid Cancer
    • Salivary Gland Cancer
    • Chicago, Illinois
      University of Chicago Comprehensive Cancer Center
    Apr 13, 2022